NBRV - Nabriva Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts4445
Avg. Estimate-0.16-0.14-0.66-0.48
Low Estimate-0.17-0.17-0.72-0.64
High Estimate-0.15-0.12-0.61-0.35
Year Ago EPS-0.3-0.24-1.12-0.66
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts3355
Avg. Estimate400k650k5.05M27.23M
Low Estimate200k250k1.59M10M
High Estimate700k1.2M9M66.8M
Year Ago Sales525kN/A9.48M5.05M
Sales Growth (year/est)-23.80%N/A-46.70%439.20%
Earnings History2019-06-292019-09-292019-12-302020-03-30
EPS Est.-0.33-0.28-0.33-0.26
EPS Actual-0.3-0.24-0.29-0.25
Difference0.030.040.040.01
Surprise %9.10%14.30%12.10%3.80%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.16-0.14-0.66-0.48
7 Days Ago-0.16-0.14-0.66-0.48
30 Days Ago-0.16-0.15-0.68-0.59
60 Days Ago-0.21-0.2-0.81-0.67
90 Days Ago-0.21-0.2-0.81-0.6
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNBRVIndustrySector(s)S&P 500
Current Qtr.46.70%N/AN/AN/A
Next Qtr.41.70%N/AN/AN/A
Current Year41.10%N/AN/AN/A
Next Year27.30%N/AN/AN/A
Next 5 Years (per annum)97.20%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A